You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Primary progressive MS

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Gray Matter Demyelination in Primary Progressive MS at 7T

Recruiting
  • Primary Progressive Multiple Sclerosis
    • Hvidovre, Denmark
      Danish Research Centre for Magnetic Resonance
    Jun 5, 2022

    Multiple Sclerosis (MS) Patients

    Not yet recruiting
    • Multiple Sclerosis, Relapsing-Remitting
    • +2 more
      • (no location specified)
      Dec 15, 2022

      Multiple Sclerosis, Primary Progressive Multiple Sclerosis, Secondary-progressive Multiple Sclerosis Trial in Belgium (Metformin

      Not yet recruiting
      • Multiple Sclerosis
      • +2 more
      • Metformin Hydrochloride 850 mg Oral Tablet
      • Placebo
      • Brugge, Belgium
      • +4 more
      May 30, 2023

      Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis, Secondary Progressive, Multiple Sclerosis, Primary Progressive

      Completed
      • Multiple Sclerosis, Relapsing-Remitting
      • +2 more
      • 18F-DPA-714 and 18F-FDG
      • Paris, France
      • +1 more
      Sep 14, 2022

      Primary Progressive Multiple Sclerosis, Secondary Progressive Multiple Sclerosis, Multiple Sclerosis Trial (Intranasal Foralumab

      Withdrawn
      • Primary Progressive Multiple Sclerosis
      • +2 more
      • Intranasal Foralumab Solution
      • Placebo
      • (no location specified)
      Feb 14, 2022

      Multiple Sclerosis (MS), Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis, Primary Progressive Trial in San Francisco

      Not yet recruiting
      • Multiple Sclerosis (MS)
      • +6 more
      • Clemastine Fumarate
      • Placebo
      • San Francisco, California
        Sandler Neurosciences Building, Neurological Clinical Research U
      Jan 23, 2023

      Multiple Sclerosis, Chronic Progressive, Multiple Sclerosis, Primary Progressive Trial in Kaposvár (Training groupe, PNF,

      Completed
      • Multiple Sclerosis, Chronic Progressive
      • Multiple Sclerosis, Primary Progressive
      • Training groupe
      • +3 more
      • Kaposvár, Somogy, Hungary
        Somogy Megyei Kaposi Mór Oktató Kórház
      Mar 24, 2022

      Secondary Progressive Multiple Sclerosis, Primary Progressive Multiple Sclerosis, Progressive Relapsing Multiple Sclerosis Trial

      Active, not recruiting
      • Secondary Progressive Multiple Sclerosis
      • +2 more
      • Minneapolis, Minnesota
      • +2 more
      Mar 29, 2022

      Primary Progressive Multiple Sclerosis, Secondary Progressive Multiple Sclerosis, Relapsing Multiple Sclerosis Trial in Boston

      Recruiting
      • Primary Progressive Multiple Sclerosis
      • +3 more
      • Boston, Massachusetts
        Brigham and Women's Hospital
      Jul 20, 2021

      Multiple Sclerosis, Primary Progressive Trial in Calgary (Hydroxychloroquine)

      Completed
      • Multiple Sclerosis, Primary Progressive
      • Calgary, Alberta, Canada
        MS Clinic Foothills Medical Centre
      Jul 28, 2021

      MS-ResearchBiomarkerS

      Recruiting
      • Multiple Sclerosis
      • +10 more
        • Los Angeles, California
          Cedars-Sinai Medical Center
        Jan 26, 2022

        Imaging Interplay Between Axonal Damage and Repair in Multiple

        Recruiting
        • Multiple Sclerosis (MS)
        • +3 more
        • MRI
        • +2 more
        • Basel, Switzerland
          University Hospital Basel, Department of Neurology
        Dec 15, 2021

        Primary Progressive Multiple Sclerosis, Secondary Progressive Multiple Sclerosis Trial in Australia, Canada, United States

        Active, not recruiting
        • Primary Progressive Multiple Sclerosis
        • Secondary Progressive Multiple Sclerosis
        • ATA188
        • Placebo
        • La Jolla, California
        • +33 more
        Jul 21, 2022

        Secondary Progressive Multiple Sclerosis, Primary Progressive Multiple Sclerosis Trial in Dublin (Fampridine, Placebo)

        Completed
        Has Results
        • Secondary Progressive Multiple Sclerosis
        • Primary Progressive Multiple Sclerosis
        • Dublin, Dublin 4, Ireland
        • +1 more
        Jul 8, 2021

        Relapsing Multiple Sclerorsis, Multiple Sclerosis, Primary Progressive Trial in Worldwide (Ocrelizumab, Lumbar Puncture,

        Active, not recruiting
        • Relapsing Multiple Sclerorsis
        • Multiple Sclerosis, Primary Progressive
        • Palo Alto, California
        • +16 more
        Jul 26, 2022

        Multiple Sclerosis, Secondary Progressive, Multiple Sclerosis Trial in Warsaw (Cladribine Subcutaneous Injection, 0.9% Chloride

        Recruiting
        • Multiple Sclerosis, Secondary Progressive
        • Multiple Sclerosis
        • Cladribine Subcutaneous Injection
        • 0.9% Chloride Injection Sodium
        • Warsaw, Mazowieckie, Poland
          Institute of Psychiatry and Neurology
        Jul 26, 2023

        MSRV-Env Burden in Patients With Multiple Sclerosis Disease

        Completed
        • Multiple Sclerosis (MS)
        • +4 more
        • No study treatments administered - blood draws only
        • Bron cedex, France
        • +3 more
        Oct 19, 2020

        Multiple Sclerosis, Chronic Progressive Trial in United States (NurOwn (MSC-NTF cells))

        Completed
        Has Results
        • Multiple Sclerosis, Chronic Progressive
        • NurOwn (MSC-NTF cells)
        • Los Angeles, California
        • +3 more
        Oct 20, 2022

        Multiple Sclerosis (MS), Multiple Sclerosis (MS) Relapsing Remitting, Multiple Sclerosis (MS) Primary Progressive Trial in

        Completed
        • Multiple Sclerosis (MS)
        • +6 more
        • Video-oculography / Social cognition tasks / Neuropsychological evaluations
        • Monaco, Monaco
          Centre Mémoire / Centre de Gérontologie Clinique Rainier III / P
        Jan 19, 2021

        Primary Aldosteronism LC-MS/MS-specific Cutoffs

        Recruiting
        • Primary Aldosteronism
        • Captopril Challenge Test
        • Chongqing, Chongqing, China
        • +1 more
        Jul 24, 2023

        Aphasia, Primary Progressive Trial in Columbia (Propranolol, Magnetic Resonance Imaging (MRI), Placebo)

        Not yet recruiting
        • Aphasia, Primary Progressive
        • Columbia, Missouri
          University of Missouri-Columbia
        Sep 27, 2023

        Multiple Sclerosis, Multiple Sclerosis, Primary Progressive, Multiple Sclerosis, Secondary Progressive Trial in Palo Alto

        Not yet recruiting
        • Multiple Sclerosis
        • +2 more
        • KYV-101 anti-CD19 CAR-T cell therapy
        • Standard lymphodepletion regimen
        • Palo Alto, California
          Stanford Multiple Sclerosis Center
        Nov 13, 2023

        Hyperaldosteronism; Primary Trial in Caen (Aldosterone in HPLC-MS/MS)

        Recruiting
        • Hyperaldosteronism; Primary
        • Aldosterone in HPLC-MS/MS
        • Caen, France
          CAEN University Hospital
        Nov 28, 2022

        Relapsing Remitting Multiple Sclerosis, Secondary Progressive Multiple Sclerosis, Primary Progressive Multiple Sclerosis Trial

        Recruiting
        • Relapsing Remitting Multiple Sclerosis
        • +2 more
        • Glostrup, Copenhagen, Denmark
        • +11 more
        May 3, 2022

        Progressive Multiple Sclerosis Trial in Lille, Strasbourg (Placebo, Masitinib (4.5))

        Recruiting
        • Progressive Multiple Sclerosis
        • Placebo
        • Masitinib (4.5)
        • Lille, France
        • +1 more
        Jul 1, 2022